Benzinga | Nov 19, 2021 10:15AM EST

Morgan Stanley Maintains Overweight on Stryker, Raises Price Target to $305

Morgan Stanley maintains Stryker (NYSE:SYK) with a Overweight and raises the price target from $295 to $305.